Lianling Yu

508 total citations
11 papers, 438 citations indexed

About

Lianling Yu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Lianling Yu has authored 11 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Lianling Yu's work include Metal complexes synthesis and properties (6 papers), Nanoparticle-Based Drug Delivery (2 papers) and Metal-Catalyzed Oxygenation Mechanisms (2 papers). Lianling Yu is often cited by papers focused on Metal complexes synthesis and properties (6 papers), Nanoparticle-Based Drug Delivery (2 papers) and Metal-Catalyzed Oxygenation Mechanisms (2 papers). Lianling Yu collaborates with scholars based in China, Hong Kong and United States. Lianling Yu's co-authors include Tianfeng Chen, Wenjie Zheng, Wenqiang Cao, Zhiqin Deng, Cundong Fan, Linlin Li, Sheng-Gui Liu, Huanying Zhang, Bin Ma and Zhennan Zhao and has published in prestigious journals such as Biomaterials, Chemical Communications and RSC Advances.

In The Last Decade

Lianling Yu

11 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lianling Yu China	9	226	161	142	66	60	11	438
Zuandi Luo China	6	207 0.9×	182 1.1×	124 0.9×	70 1.1×	84 1.4×	8	412
Paul Cressey United Kingdom	12	266 1.2×	170 1.1×	170 1.2×	131 2.0×	64 1.1×	21	515
Merve Erkısa Türkiye	16	245 1.1×	260 1.6×	254 1.8×	61 0.9×	79 1.3×	37	687
Zhenlei Zhang China	13	203 0.9×	101 0.6×	150 1.1×	33 0.5×	79 1.3×	22	442
Bing-Jie Han China	17	415 1.8×	343 2.1×	284 2.0×	67 1.0×	75 1.3×	31	760
Matthias H. M. Klose Austria	14	212 0.9×	216 1.3×	123 0.9×	22 0.3×	45 0.8×	18	420
Michele De Franco Italy	15	202 0.9×	269 1.7×	151 1.1×	49 0.7×	33 0.6×	32	532
Dajena Tomco United States	6	439 1.9×	327 2.0×	166 1.2×	37 0.6×	78 1.3×	8	650
Arvin Eskandari United Kingdom	15	454 2.0×	272 1.7×	249 1.8×	84 1.3×	138 2.3×	23	741

Countries citing papers authored by Lianling Yu

Since Specialization

Citations

This map shows the geographic impact of Lianling Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianling Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianling Yu more than expected).

Fields of papers citing papers by Lianling Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianling Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianling Yu. The network helps show where Lianling Yu may publish in the future.

Co-authorship network of co-authors of Lianling Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lianling Yu. A scholar is included among the top collaborators of Lianling Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianling Yu. Lianling Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Li, Fangfang, Lianling Yu, & Jun Zhu. (2020). <p>LncRNA PSMA3-AS1 Promotes Lung Cancer Growth and Invasion via Sponging MiR-4504</p>. Cancer Management and Research. Volume 12. 5277–5283. 13 indexed citations

Zhang, Jinling, et al.. (2020). Modified nodal stage of esophageal cancer based on the evaluation of the hazard rate of the negative and positive lymph node. BMC Cancer. 20(1). 1200–1200. 3 indexed citations

Yu, Lianling, et al.. (2017). Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy. Biomedicine & Pharmacotherapy. 91. 287–294. 59 indexed citations

Deng, Zhiqin, Pan Gao, Lianling Yu, et al.. (2017). Ruthenium complexes with phenylterpyridine derivatives target cell membrane and trigger death receptors-mediated apoptosis in cancer cells. Biomaterials. 129. 111–126. 64 indexed citations

Yu, Lianling, et al.. (2017). Electrical acupuncture moderately decreases cardiac ischemia-reperfusion injury in rats. Acupuncture & Electro-Therapeutics Research. 42(3-4). 203–216. 1 indexed citations

Zhang, Huanying, et al.. (2016). Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation. Biomedicine & Pharmacotherapy. 86. 547–554. 32 indexed citations

Ma, Lijuan, Yuanting Fu, Lianling Yu, et al.. (2015). Ruthenium complexes as inhibitors of human islet amyloid polypeptide aggregation, an effect that prevents beta cell apoptosis. RSC Advances. 5(23). 17405–17412. 19 indexed citations

Deng, Zhiqin, Lianling Yu, Wenqiang Cao, Wenjie Zheng, & Tianfeng Chen. (2015). Rational Design of Ruthenium Complexes Containing 2,6‐Bis(benzimidazolyl)pyridine Derivatives with Radiosensitization Activity by Enhancing p53 Activation. ChemMedChem. 10(6). 991–998. 23 indexed citations

Deng, Zhiqin, Lianling Yu, Wenqiang Cao, Wenjie Zheng, & Tianfeng Chen. (2015). A selenium-containing ruthenium complex as a cancer radiosensitizer, rational design and the important role of ROS-mediated signalling. Chemical Communications. 51(13). 2637–2640. 60 indexed citations

10.

Luo, Zuandi, Lianling Yu, Fang Yang, et al.. (2014). Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase. Metallomics. 6(8). 1480–1490. 83 indexed citations

11.

Liu, Sheng-Gui, Wenqiang Cao, Lianling Yu, et al.. (2013). Zinc(ii) complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers that trigger DNA damage-mediated p53 phosphorylation in cancer cells. Dalton Transactions. 42(16). 5932–5932. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact